These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20945981)

  • 1. Quantification of α-synuclein in cerebrospinal fluid as a biomarker candidate: review of the literature and considerations for future studies.
    Mollenhauer B; El-Agnaf OM; Marcus K; Trenkwalder C; Schlossmacher MG
    Biomark Med; 2010 Oct; 4(5):683-99. PubMed ID: 20945981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid alpha-synuclein in neurodegenerative disorders-a marker of synapse loss?
    Ohrfelt A; Grognet P; Andreasen N; Wallin A; Vanmechelen E; Blennow K; Zetterberg H
    Neurosci Lett; 2009 Feb; 450(3):332-5. PubMed ID: 19022350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson's disease.
    El-Agnaf OM; Salem SA; Paleologou KE; Curran MD; Gibson MJ; Court JA; Schlossmacher MG; Allsop D
    FASEB J; 2006 Mar; 20(3):419-25. PubMed ID: 16507759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitive and specific detection of α-synuclein in human plasma.
    Tinsley RB; Kotschet K; Modesto D; Ng H; Wang Y; Nagley P; Shaw G; Horne MK
    J Neurosci Res; 2010 Sep; 88(12):2693-700. PubMed ID: 20648655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased alpha-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's disease.
    Tokuda T; Salem SA; Allsop D; Mizuno T; Nakagawa M; Qureshi MM; Locascio JJ; Schlossmacher MG; El-Agnaf OM
    Biochem Biophys Res Commun; 2006 Oct; 349(1):162-6. PubMed ID: 16930553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of α-synuclein in cerebrospinal fluid: how ideal is this biomarker for Parkinson's disease?
    Mollenhauer B
    Parkinsonism Relat Disord; 2014 Jan; 20 Suppl 1():S76-9. PubMed ID: 24262194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSF α-synuclein does not differentiate between parkinsonian disorders.
    Aerts MB; Esselink RA; Abdo WF; Bloem BR; Verbeek MM
    Neurobiol Aging; 2012 Feb; 33(2):430.e1-3. PubMed ID: 21236518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of electrochemiluminescence-based singleplex and multiplex assays for the quantification of α-synuclein and other proteins in cerebrospinal fluid.
    Kruse N; Schulz-Schaeffer WJ; Schlossmacher MG; Mollenhauer B
    Methods; 2012 Apr; 56(4):514-8. PubMed ID: 22465793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A more efficient enzyme-linked immunosorbent assay for measurement of alpha-synuclein in cerebrospinal fluid.
    van Geel WJ; Abdo WF; Melis R; Williams S; Bloem BR; Verbeek MM
    J Neurosci Methods; 2008 Feb; 168(1):182-5. PubMed ID: 17976734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma alpha-synuclein in patients with Parkinson's disease with and without treatment.
    Duran R; Barrero FJ; Morales B; Luna JD; Ramirez M; Vives F
    Mov Disord; 2010 Mar; 25(4):489-93. PubMed ID: 20063406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of cerebrospinal fluid α-synuclein species as biomarker in Parkinson's diagnosis and prognosis.
    Parnetti L; Cicognola C; Eusebi P; Chiasserini D
    Biomark Med; 2016; 10(1):35-49. PubMed ID: 26643452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylated α-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's disease.
    Foulds PG; Mitchell JD; Parker A; Turner R; Green G; Diggle P; Hasegawa M; Taylor M; Mann D; Allsop D
    FASEB J; 2011 Dec; 25(12):4127-37. PubMed ID: 21865317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of elevated levels of α-synuclein oligomers in CSF from patients with Parkinson disease.
    Tokuda T; Qureshi MM; Ardah MT; Varghese S; Shehab SA; Kasai T; Ishigami N; Tamaoka A; Nakagawa M; El-Agnaf OM
    Neurology; 2010 Nov; 75(20):1766-72. PubMed ID: 20962290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alimentary, my dear Watson? The challenges of enteric α-synuclein as a Parkinson's disease biomarker.
    Visanji NP; Marras C; Hazrati LN; Liu LW; Lang AE
    Mov Disord; 2014 Apr; 29(4):444-50. PubMed ID: 24375496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: new targets for drug discovery.
    Lee VM; Trojanowski JQ
    Neuron; 2006 Oct; 52(1):33-8. PubMed ID: 17015225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Alpha-Synuclein in blood and cerebrospinal fluid of patients with alpha-synucleinopathy].
    Ono K; Yamada M
    Rinsho Byori; 2014 Mar; 62(3):241-5. PubMed ID: 24800499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
    Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
    Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of α-synuclein oligomers in red blood cells as a potential biomarker of Parkinson's disease.
    Wang X; Yu S; Li F; Feng T
    Neurosci Lett; 2015 Jul; 599():115-9. PubMed ID: 25998655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma alpha-synuclein is decreased in subjects with Parkinson's disease.
    Li QX; Mok SS; Laughton KM; McLean CA; Cappai R; Masters CL; Culvenor JG; Horne MK
    Exp Neurol; 2007 Apr; 204(2):583-8. PubMed ID: 17258710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of alpha-synuclein concentration in human plasma using ELISA.
    Fjorback AW; Varming K; Jensen PH
    Scand J Clin Lab Invest; 2007; 67(4):431-5. PubMed ID: 17558898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.